~~<i id='C23E3FAA35'><strike id='C23E3FAA35'><tt id='C23E3FAA35'><pre id='C23E3FAA35'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

Wikipedia

author：entertainment 2025-10-02 05:54:43 - browse：132

The FDA has taken a big step in encouraging drug companies to include pregnant women in clinical trials, issuing a draft guidance outlining how to do so safely and ethically.

Nearly 4 million women in the U.S. give birth each year, but few drugs have been approved as safe and effective to use during pregnancy. The new guidance aims to help drug companies address those information gaps “through judicious inclusion of pregnant women in clinical trials and careful attention to potential fetal risk.”

Experts say it’s a sign of progress on an issue that’s long plagued pregnant women and their physicians.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Most antidepressants don't work on kids, teens, study finds

knowledge

hotspot

Fromleft:DaphneKoller,CEOofInsitro,VijayPandeofAndreessenHorowitzandscientistDerekLowespeakingatSTAT

WSS

The creative science of coining drug names

R.J. Reynolds sues to protect 'crisp' cigs from California flavor ban

WuXi out of biotech trade group, U.S. and China relations to blame

As health system earnings go up, health insurance stocks go down

EPA limits use of carcinogenic gas for sterilizing medical devices

Welsh Carson private equity firm escapes from FTC antitrust case

knowledge

Wikipedia

knowledge

At least 13 dead in Texas as scorching temps continue

Most antidepressants don't work on kids, teens, study finds

Anesthesiologist group: stop taking Ozempic before surgery

As AI in medicine takes off, can 'human in the loop' prevent harm?

Sports medicine is finally prioritizing gender equality

HHS's proposed rule does nothing to address the climate crisis

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How many hemophilia patients actually want gene therapy?

Novavax promises a turnaround & Lilly roils the obesity market

Empower primary care with adequate payments and technology

hotspot

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

BIO to announce reorganization, senior leaders expected to depart

Pushing for an NIH office for post

John Green on his newest strategy for fighting tuberculosis

Chemotherapy before breast cancer surgery might fuel metastasis

As billionaires fund anti

hotspot

hotspot

hotspot

hotspot